15 Oct 2026Zydus Lifesciences Ltd signs agreement with Board of Investment, Sri Lanka to establish pharmaceutical manufacturing facility via JV with Sunshine HealthcareMOU
1 Oct 2026Zydus Lifesciences Ltd extends closing date for 50:50 JV with Sunshine Healthcare Lanka to Dec 2026Restructuring
11 Sept 2026Zydus Lifesciences Ltd credit rating reaffirmed: CRISIL AAA/Stable by CRISIL on 11 Sep 2026Credit Ratings
3 Jun 2026Zydus Lifesciences Limited buyback advertisement submission for up to 87,30,158 equity shares at INR 1,260 per share for aggregate amount of INR 1,100 crores through tender offer route with record date May 29, 2026Record Date
1 Jun 2026Zydus Lifesciences Limited buyback of 87,30,158 equity shares at INR 1,260 per share for aggregate amount of INR 1,100 crores through tender offer route with record date May 29, 2026Record Date
31 May 2026Zydus Lifesciences Limited buyback announcement for up to 87,30,158 equity shares at INR 1,260 per share through tender offer route scheduled from June 4, 2026 to June 10, 2026Record Date
21 May 2026Zydus Lifesciences Limited public announcement for buyback of equity shares worth INR 1,100 crores at INR 1,150 per share through tender offer route scheduled on May 21, 2026Record Date
20 May 2026ZYDUS LIFESCIENCES LIMITED Annual Secretarial Compliance Certificate for FY26 under Regulation 24A(2) scheduled on May 19, 2026Audit Reports
19 May 2026ZYDUS LIFESCIENCES LIMITED record date announcement for FY26 under Regulation 42 scheduled on July 24, 2026Record Date
19 May 2026Zydus Lifesciences Limited board resolution approving buyback of up to 95,65,217 equity shares at INR 1,150 per share for aggregate amount not exceeding INR 1,100 crores under SEBI Buyback Regulations scheduled on May 19, 2026Record Date
19 May 2026Zydus Lifesciences Limited buyback approval for up to 95,65,217 equity shares at INR 1,150 per share under Regulation 30 with record date May 29, 2026Record Date
